Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP213047.RA1LbOyo6fSg7kxx5-aYBJRVvu8vqD0oe3Y_DYkyIARIc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP213047.RA1LbOyo6fSg7kxx5-aYBJRVvu8vqD0oe3Y_DYkyIARIc130_assertion type Assertion NP213047.RA1LbOyo6fSg7kxx5-aYBJRVvu8vqD0oe3Y_DYkyIARIc130_head.
- NP213047.RA1LbOyo6fSg7kxx5-aYBJRVvu8vqD0oe3Y_DYkyIARIc130_assertion description "[The NUP98-DDX10 fusion transcript may promote the development of secondary hematological malignancies caused by DNA-topoisomerase II inhibitors through aberrant nucleocytoplasmic transport and/or alteration in ribosome assembly.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP213047.RA1LbOyo6fSg7kxx5-aYBJRVvu8vqD0oe3Y_DYkyIARIc130_provenance.
- NP213047.RA1LbOyo6fSg7kxx5-aYBJRVvu8vqD0oe3Y_DYkyIARIc130_assertion evidence source_evidence_literature NP213047.RA1LbOyo6fSg7kxx5-aYBJRVvu8vqD0oe3Y_DYkyIARIc130_provenance.
- NP213047.RA1LbOyo6fSg7kxx5-aYBJRVvu8vqD0oe3Y_DYkyIARIc130_assertion SIO_000772 10830185 NP213047.RA1LbOyo6fSg7kxx5-aYBJRVvu8vqD0oe3Y_DYkyIARIc130_provenance.
- NP213047.RA1LbOyo6fSg7kxx5-aYBJRVvu8vqD0oe3Y_DYkyIARIc130_assertion wasDerivedFrom befree-20140225 NP213047.RA1LbOyo6fSg7kxx5-aYBJRVvu8vqD0oe3Y_DYkyIARIc130_provenance.
- NP213047.RA1LbOyo6fSg7kxx5-aYBJRVvu8vqD0oe3Y_DYkyIARIc130_assertion wasGeneratedBy ECO_0000203 NP213047.RA1LbOyo6fSg7kxx5-aYBJRVvu8vqD0oe3Y_DYkyIARIc130_provenance.